CHOP T-Cell Acute Lymphoblastic Leukemia Study (BEAM-201)

CHOP T-Cell Acute Lymphoblastic Leukemia Study (BEAM-201)

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description

The purpose of this study is to test a cell therapy for T-Cell Lymphoblastic Leukemia or Lymphoma. The CAR T-cells are made by collecting T-cells from donors and modifying them to attach to cancer cells. CAR T-cells have been used to treat other cancers, but these cells, known as BEAM-201 cells, are an experimental treatment. The participants will be given BEAM-201 cells via an IV and then monitored for up to 12 months.

This study will assess the safety and effectiveness of BEAM-201 cells.

What to expect

This study will take place at the Children's Hospital of Philadelphia. Participation lasts for up to 12 months. Possible procedures include:

  • BEAM-201 cell infusion via IV
  • Blood draws
  • Physical exams
  • Imaging
  • Bone marrow testing
  • Lumbar puncture

Related specialties

Related conditions
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.